Skip to Main Content

Paper Details

Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy.
J Clin Lipidol
13
2019
Author NameAffiliation
Jessica MinnierCenter for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University
Michael D ShapiroCenter for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University
  • 1 - 2

Datasets

Release 1.2